Quick Answer
Turn Therapeutics Inc. reported R&D Expense of $265.6 thousand for fiscal year 2025.
Turn Therapeutics Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $265.6K | +8.0% |
| 2024 | $246.0K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $158.7K | +3.5% | +3.5% |
| September 30, 2024 | $153.3K | — | — |
- Turn Therapeutics Inc. showed an increase of +8.0% in R&D Expense compared to the prior fiscal year.
- Over the 2024–2025 period, Turn Therapeutics Inc.’s r&d expense has grown by 8.0% (from $246.0 thousand to $265.6 thousand).
- The most recent figure is from Turn Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: